CAT No: OPO-029
CAS No: 556-33-2
Synonyms/Alias: 556-33-2;Glycylglycylglycine;Triglycine;Glycyl-glycyl-glycine;H-Gly-Gly-Gly-OH;Gly-Gly-Gly;Diglycylglycine;N-(N-Glycylglycyl)glycine;Glycine, glycylglycyl-;GlyGlyGly;2-(2-(2-Aminoacetamido)acetamido)acetic acid;2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid;Glycine, N-(N-glycylglycyl)-;UNII-CVK73ZDQ8B;MFCD00036223;CHEBI:63961;(Gly)3;EINECS 209-122-0;NSC 46707;NSC-46707;CVK73ZDQ8B;TRIGLYCINE [USP-RS];CHEMBL54278;DTXSID80204140;Gly-Gly-Gly-OH;TRIGLYCINE (USP-RS);[2-(2-Amino-acetylamino)-acetylamino]-acetic acid;2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetic Acid (Triglycine);2-[2-(2-aminoacetamido)acetamido]acetic acid;2-((2-((2-aminoacetyl)amino)acetyl)amino)acetic acid;2-((2-((2-azaniumylacetyl)amino)acetyl)amino)acetate;2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetate;Glycylpeptide;2-({2-[(2-AMINOACETYL)AMINO]ACETYL}AMINO)ACETIC ACID;diglycyl-glycine;GGG peptide;Triglycine (van);NSC46707;N(NGlycylglycyl)glycine;Maybridge1_006812;SCHEMBL98565;N-(N-GLYCYLGLYCYL)-Glycine;HMS560N14;DTXCID80126631;Glycine, N(Nglycylglycyl) (8CI);OGG-3061;BDBM50188484;Glycine, N-(N-glycylglycyl)-(8CI);AKOS005207234;CS-W015952;DS-7430;FG39666;HY-W015236;BP-31100;Glycine, N(Nglycylglycyl) (8CI)(9CI);SY025319;Glycine, N-(N-glycylglycyl)-(8CI)(9CI);G0126;Gly-Gly-Gly, BioUltra, >=99.0% (NT);NS00033358;Glycine, N-(N-glycylglycyl)- (8CI)(9CI);(([(Aminoacetyl)amino]acetyl)amino)acetic acid;3,6-Diazaoctanoic acid, 8-amino-4,7-dioxo-;EN300-176110;F17230;Glycylglycylglycine, 98+% (H-Gly-Gly-Gly-OH);(([(Aminoacetyl)amino]acetyl)amino)acetic acid #;Q27132936;Triglycine, United States Pharmacopeia (USP) Reference Standard;
Chemical Name: 2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C6H11N3O4 |
M.W/Mr. | 189.17 |
Sequence | One Letter Code:GGG Three Letter Code:H-Gly-Gly-Gly-OH |
InChI | InChI=1S/C6H11N3O4/c7-1-4(10)8-2-5(11)9-3-6(12)13/h1-3,7H2,(H,8,10)(H,9,11)(H,12,13) |
InChI Key | XKUKSGPZAADMRA-UHFFFAOYSA-N |
Canonical SMILES | C(C(=O)NCC(=O)NCC(=O)O)N |
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com